Literature DB >> 24682763

Current status of oral cancer treatment strategies: surgical treatments for oral squamous cell carcinoma.

Ken Omura1.   

Abstract

The primary treatment modality of oral cancer is generally determined according to the stage of the disease, with surgical treatment remaining the mainstay of multimodal treatment. When selecting the treatment, many factors are taken into consideration, and the treatment should be tailored individually to the patient's needs and consider the quality of life as well as the survival of the patient. Early-stage disease is primarily managed with surgery or brachytherapy without functional morbidity, whereas for advanced-stage disease multidisciplinary treatment is recommended, not only for enhanced survival but also for improved quality of life. After resection of large primary tumors, reconstructive surgery is required. Free tissue transfer currently represents one of the most popular and reliable techniques for oral reconstruction. For cN0 neck, elective neck dissection is recommended when the risk of occult metastases is >20 %, when the neck is entered either for resection of the primary tumor or for reconstruction, or when the patient is unlikely to return for a close follow-up. Sentinel node biopsy is performed investigationally. Modified radical neck dissection is the gold standard for cN+ neck. For patients with multiple node metastases or extracapsular spread, postoperative radiotherapy or chemoradiotherapy is recommended, with the lymph nodes situated outside the confines of the radical neck dissection, such as the lingual and retropharyngeal nodes, receiving considerable attention. Targeted therapy for oral cancer is still a relatively new concept, and more studies are needed to confirm the clinical effectiveness of these drugs.

Entities:  

Mesh:

Year:  2014        PMID: 24682763     DOI: 10.1007/s10147-014-0689-z

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  81 in total

1.  Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience.

Authors:  K T Robbins; P Kumar; W F Regine; F S Wong; A B Weir; P Flick; L E Kun; R Palmer; T Murry; J Fontanesi; R Ferguson; R Thomas; W Hartsell; C U Paig; G Salazar; L Norfleet; C B Hanchett; V Harrington; H B Niell
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-05-01       Impact factor: 7.038

Review 2.  Speech and swallowing following tongue cancer surgery and free flap reconstruction--a systematic review.

Authors:  Lisetta Lam; Nabil Samman
Journal:  Oral Oncol       Date:  2013-04-06       Impact factor: 5.337

3.  Vital staining with iodine solution in oral cancer: iodine infiltration, cell proliferation, and glucose transporter 1.

Authors:  Tiepeng Xiao; Hiroshi Kurita; Tetsu Shimane; Yoshitaka Nakanishi; Takeshi Koike
Journal:  Int J Clin Oncol       Date:  2012-07-25       Impact factor: 3.402

4.  High expressions of CD105 and VEGF in early oral cancer predict potential cervical metastasis.

Authors:  Chih-Yen Chien; Chih-Ying Su; Chung-Feng Hwang; Hui-Ching Chuang; Ching-Mei Chen; Chao-Cheng Huang
Journal:  J Surg Oncol       Date:  2006-10-01       Impact factor: 3.454

5.  Preoperative assessment for and outcomes of mandibular conservation surgery.

Authors:  J W Werning; R M Byers; M A Novas; D Roberts
Journal:  Head Neck       Date:  2001-12       Impact factor: 3.147

6.  A review of 716 consecutive free flaps for oncologic surgical defects: refinement in donor-site selection and technique.

Authors:  D A Hidalgo; J J Disa; P G Cordeiro; Q Y Hu
Journal:  Plast Reconstr Surg       Date:  1998-09       Impact factor: 4.730

Review 7.  Use of decision analysis in planning a management strategy for the stage N0 neck.

Authors:  M H Weiss; L B Harrison; R S Isaacs
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1994-07

8.  Modified radical neck dissection. Terminology, technique, and indications.

Authors:  C J O'Brien; M M Urist; W A Maddox
Journal:  Am J Surg       Date:  1987-03       Impact factor: 2.565

9.  Epidemiological study of malignant tumors in the oral and maxillofacial region: survey of member institutions of the Japanese Society of Oral and Maxillofacial Surgeons, 2002.

Authors:  Yasunori Ariyoshi; Masashi Shimahara; Ken Omura; Etsuhide Yamamoto; Harumi Mizuki; Hiroshige Chiba; Yutaka Imai; Shigeyuki Fujita; Masanori Shinohara; Kanichi Seto
Journal:  Int J Clin Oncol       Date:  2008-06-14       Impact factor: 3.402

10.  Multiple primary cancers in patients with squamous cell carcinoma of the oral cavity.

Authors:  M Saikawa; S Ebihara; T Yoshizumi; W Ohyama
Journal:  Jpn J Cancer Res       Date:  1991-01
View more
  56 in total

1.  A Gingiva-Derived Mesenchymal Stem Cell-Laden Porcine Small Intestinal Submucosa Extracellular Matrix Construct Promotes Myomucosal Regeneration of the Tongue.

Authors:  Qilin Xu; Rabie M Shanti; Qunzhou Zhang; Steven B Cannady; Bert W O'Malley; Anh D Le
Journal:  Tissue Eng Part A       Date:  2017-01-04       Impact factor: 3.845

2.  Association of Lymphovascular Space Invasion With Locoregional Failure and Survival in Patients With Node-Negative Oral Tongue Cancers.

Authors:  Richard J Cassidy; Jeffrey M Switchenko; Naresh Jegadeesh; Mutlay Sayan; Matthew J Ferris; Bree R Eaton; Kristin A Higgins; Jeffrey T Wadsworth; Kelly R Magliocca; Nabil F Saba; Jonathan J Beitler
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-04-01       Impact factor: 6.223

3.  Long non-coding RNA TIRY promotes tumor metastasis by enhancing epithelial-to-mesenchymal transition in oral cancer.

Authors:  Nuo Jin; Nianqiang Jin; Wenhuan Bu; Xing Li; Lili Liu; Zilin Wang; Jin Tong; Dechao Li
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-26

4.  Inferring novel genes related to oral cancer with a network embedding method and one-class learning algorithms.

Authors:  Lei Chen; Yu-Hang Zhang; Guohua Huang; Xiaoyong Pan; Tao Huang; Yu-Dong Cai
Journal:  Gene Ther       Date:  2019-08-27       Impact factor: 5.250

5.  The histologic risk model is a useful and inexpensive tool to assess risk of recurrence and death in stage I or II squamous cell carcinoma of tongue and floor of mouth.

Authors:  Namita Sinha; Matthew H Rigby; Michael L McNeil; S Mark Taylor; Jonathan Rb Trites; Robert D Hart; Martin J Bullock
Journal:  Mod Pathol       Date:  2018-02-02       Impact factor: 7.842

6.  Artesunate targets oral tongue squamous cell carcinoma via mitochondrial dysfunction-dependent oxidative damage and Akt/AMPK/mTOR inhibition.

Authors:  Qingfeng Xiao; Lei Yang; Hao Hu; Yue Ke
Journal:  J Bioenerg Biomembr       Date:  2020-01-21       Impact factor: 2.945

7.  Focused ultrasound ablation of a large canine oral tumor achieves efficient tumor remission: a case report.

Authors:  Ashish Ranjan; Deepan Kishore; Harshini Ashar; Tina Neel; Akansha Singh; Sunil More
Journal:  Int J Hyperthermia       Date:  2021       Impact factor: 3.914

8.  High Expression of MTA1 Predicts Unfavorable Survival in Patients With Oral Squamous Cell Carcinoma.

Authors:  Kuan-Yu Lin; Tzu-Cheng Su; Chung-Min Yeh; Wan-Ru Chao; Wen-Wei Sung
Journal:  In Vivo       Date:  2021 Jul-Aug       Impact factor: 2.155

Review 9.  Locoregional Flap Reconstruction Following Oromaxillofacial Oncologic Surgery in Dogs and Cats: A Review and Decisional Algorithm.

Authors:  Michel Guzu; Diego Rossetti; Philippe R Hennet
Journal:  Front Vet Sci       Date:  2021-05-21

10.  Levofloxacin might be safe to use for OSCC patients.

Authors:  Levent Aydemir; Elif Sinem Iplik; Baris Ertugrul; Goksu Kasarci; Merve Nur Atas; Murat Ulusan; Arzu Ergen; Bedia Cakmakoglu
Journal:  Med Oncol       Date:  2021-06-25       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.